Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648].
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
8
6
2021
Statut:
epublish
Résumé
[This corrects the article DOI: 10.1016/j.gore.2020.100648.].
Identifiants
pubmed: 34095420
doi: 10.1016/j.gore.2021.100740
pii: S2352-5789(21)00045-X
pmc: PMC8169695
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
100740Commentaires et corrections
Type : ErratumFor
Informations de copyright
© 2021 The Author(s).